NeuroPace Inc Chief Financial Officer Patrick F. Williams filed a Form 4 on November 17, 2026, disclosing an open-market purchase of 11,891 shares of common stock on that same date.

Key Highlights

  • Reporting person: Patrick F. Williams, Chief Financial Officer of NeuroPace Inc (NASDAQ:NPCE)
  • Transaction: Purchase (transaction code P) of 11,891 shares of common stock on November 17, 2026
  • Weighted average price: $8.3381 per share, with individual transactions ranging from $7.93 to $8.50, inclusive
  • Post-transaction ownership: 79,399 shares of common stock held directly following the reported purchase
  • Rule 10b-18 compliance: The filing states purchases were made in compliance with SEC Rule 10b-18 safe harbor restrictions for manner, timing, price, and volume
  • Pre-clearance: According to the filing, purchases also complied with broker-dealer and issuer pre-clearance procedures

NeuroPace CFO Discloses Open-Market Common Stock Purchase in November 2026

According to the Form 4 filing submitted to the U.S. Securities and Exchange Commission, Patrick F. Williams, the Chief Financial Officer of NeuroPace Inc, purchased 11,891 shares of the company's common stock on November 17, 2026. The transaction is reported under transaction code P, indicating an open-market purchase. The filing lists the company's ticker as NPCE on NASDAQ.

The filing reports a weighted average price of $8.3381 per share. Per footnote 2, the shares were acquired across multiple transactions at prices ranging from $7.93 to $8.50, inclusive. The filing states that Williams "undertakes to provide the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (2) to this Form 4." Following the reported transaction, Williams directly holds 79,399 shares of NeuroPace common stock, according to the filing.

The filing notes in footnote 1 that the purchases were made in compliance with SEC Rule 10b-18 safe harbor restrictions covering manner, timing, price, and volume of purchase, and that purchases also complied with broker-dealer and issuer pre-clearance procedures. No derivative securities transactions were reported. The form was signed by Leah Akin as Attorney-in-Fact on November 17, 2026.

What Was Disclosed

NeuroPace CFO Patrick F. Williams reported a direct open-market purchase of 11,891 shares of common stock at a weighted average price of $8.3381 on November 17, 2026, bringing his total direct beneficial ownership to 79,399 shares.